Non-Hodgkin's Lymphoma (NHL) in children and adolescents include Burkitt's lymphoma (BL),
diffuse large B cell lymphoma (DLBL), anaplastic large cell lymphoma (ALCL) and
lymphoblastic lymphoma (LBL). These subtypes of NHL are an aggressive group of diseases. At
present, in developed countries, 80 to 90% of children with NHL are cured by intensive,
risk-adapted chemotherapy.The best protocols include BFM-90, LMB-89 and FAB/LMB/96. However,
in developing countries, such as those with low and moderate incomes, the limited
availability of resources is an obstacle for using these complicated and intensive
protocols.As such, very simple protocols, such as the CHOP protocol, were often used to
treat children and adolescents with NHL, thus resulting in poor survival rates. To improve
the survival rate of Chinese children and adolescents with NHL, This study was designed to
evaluate the efficacy and toxicity of this modified NHL-BFM -90 protocol in Chinese children
and adolescents with NHL.
Interventional
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
The event free survival (EFS)
The event free survival (EFS) was defined as the time from the start of treatment to one of the following events: death from any cause, disease progression during treatment, relapse, or to the date of the last follow up if patient did not experience any event.
Up to 5 years
No
China: Ethics Committee
Ped-No-1
NCT01761500
March 1998
December 2011
Name | Location |
---|